Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
29/10/26	€33.20	-.--%	2

End-of-day quote Bratislava S.E.

More quotes

End-of-day quote Bratislava S.E. 29/10/2026			5-day change	1st Jan Change
33.20 ^EUR	-.--%		-.--%	+10.67%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 217M 199M 180M 339M 22.97B 347M 2.37B 952M 12.16B 912M 893M 38.51B	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	242M 216M 198M 180M 338M 22.89B 346M 2.37B 949M 12.12B 909M 890M 38.39B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Zentiva announces sale from Advent to GTCR	RE
11/09/25	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
11/09/25	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
11/09/25	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
21/02/13	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

1 month	+7.10%
3 months	+7.10%
6 months	+10.67%
Current year	+10.67%

Zentiva, Stock

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news: Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Price Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

Quotes

1 month	31	33.2
Current year	29	33.2
1 year	29	33.2
3 years	24	45
5 years	24	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	12/11/2015
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	18/08/2022

Director	Title	Age	Since
Mojmír Krutý BRD	Director/Board Member	-	08/07/2013
Martin Albert BRD	Director/Board Member	-	18/10/2018
Kenneth Lynard BRD	Director/Board Member	58	15/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	-.--%	-.--%	-26.22%	+10.67%	60.36M
ELI LILLY AND COMPANY	+0.61%	+10.07%	+56.36%	+149.73%	1,263B
JOHNSON & JOHNSON	+3.81%	+1.95%	+47.88%	+82.58%	665B
ABBVIE INC.	+3.09%	+3.09%	+36.56%	+108.48%	521B
ROCHE HOLDING AG	-0.42%	-1.69%	+48.96%	+66.52%	387B
MERCK & CO., INC.	+3.93%	+6.69%	+79.30%	+45.44%	371B
NOVARTIS AG	-0.48%	+1.27%	+31.90%	+59.05%	310B
ASTRAZENECA PLC	+0.06%	+7.51%	+12.71%	+36.55%	293B
AMGEN INC.	+3.73%	+5.90%	+61.27%	+77.31%	259B
GILEAD SCIENCES, INC.	+4.19%	+9.60%	+41.85%	+113.85%	216B
Average	+1.36%	+5.74%	+39.06%	+75.02%	428.55B
Weighted average by Cap.	+1.30%	+5.96%	+48.76%	+97.27%

	2017	2018
Net sales	143M 127M 117M 106M 199M 13.48B 204M 1.39B 559M 7.14B 536M 524M 22.61B	36.17M 32.23M 29.56M 26.86M 50.5M 3.42B 51.66M 353M 142M 1.81B 136M 133M 5.73B
Net income	77.98M 69.48M 63.72M 57.91M 109M 7.37B 111M 762M 305M 3.9B 293M 286M 12.36B	2.29M 2.04M 1.87M 1.7M 3.2M 216M 3.27M 22.37M 8.97M 115M 8.6M 8.41M 363M
Net Debt	-0.09 -0.08 -0.08 -0.07 -0.13 -8.69 -0.13 -0.9 -0.36 -4.6 -0.35 -0.34 -14.58	-0.77 -0.69 -0.63 -0.57 -1.08 -73.15 -1.11 -7.56 -3.03 -38.71 -2.91 -2.84 -122.64